Lipopolysaccharide-instructed, cryopreserved, human monocytes sequentially convert plasma fibrinogen to fibrin and lyse the fibrin formed.

Distinction between fibrinogen and fibrin degradation products in plasma.

Anticlotting properties of fragments D from human fibrinogen and fibrin.

Affinity chromatography of soluble fibrin in human plasma on insolubilized fibrinogen and fragment D.

Surface properties of fibrinogen and fibrin.

Immunohistochemical detection of extravasated fibrinogen (fibrin) in human diabetic retina.

Insoluble "fibrin" in human aortic intima. Quantitative studies on the relationship between insoluble "fibrin", soluble fibrinogen and low density lipoprotein.

fibrinogen degradation products in pleural exudate.

Quantitative N-terminal analysis of fibrinogen-fibrin-related antigen [FR antigen] from human plasma.

fibrin complexes in pre-eclampsia.

Fibrin-fibrinogen degradation products in cerebrospinal fluid.

fibrinogen complexes.

Induction of fibrin thrombi by monocytes.

Impact of fibrinogen carbamylation on fibrin clot formation and stability.

Infinite-dilution viscoelastic properties of fibrinogen and intermediate fibrin polymer.

Fibrinogen- and fibrin-degradation products during fibrinolytic therapy.

Separation of human des-AB fibrin and fibrinogen by sepharose-plasma chromatography at 20 degrees C and 37 degrees C.

A method for characterising serum fibrinogen and fibrin degradation products.

Fibrin and fibrinogen degradation products in chronic subdural hematoma.

Estimation of fibrinogen-fibrin related antigen by continuous flow analysis.

fibrinogen degradation products in glomerulonephritis.

Urinary fibrin-fibrinogen degradation products in nephrotic syndrome.

Isolation of vasoactive peptides from human fibrin and fibrinogen degraded by plasmin.

Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers.

Autologous whole plasma fibrin gel. Intraoperative procurement.

Suggest Documents

Distinction between fibrinogen and fibrin degradation products in plasma.

Anticlotting properties of fragments D from human fibrinogen and fibrin.

Affinity chromatography of soluble fibrin in human plasma on insolubilized fibrinogen and fragment D.

Surface properties of fibrinogen and fibrin.

Immunohistochemical detection of extravasated fibrinogen (fibrin) in human diabetic retina.

Insoluble "fibrin" in human aortic intima. Quantitative studies on the relationship between insoluble "fibrin", soluble fibrinogen and low density lipoprotein.

fibrinogen degradation products in pleural exudate.

Quantitative N-terminal analysis of fibrinogen-fibrin-related antigen [FR antigen] from human plasma.

fibrin complexes in pre-eclampsia.

Fibrin-fibrinogen degradation products in cerebrospinal fluid.

fibrinogen complexes.

Induction of fibrin thrombi by monocytes.

Impact of fibrinogen carbamylation on fibrin clot formation and stability.

Infinite-dilution viscoelastic properties of fibrinogen and intermediate fibrin polymer.

Fibrinogen- and fibrin-degradation products during fibrinolytic therapy.

Separation of human des-AB fibrin and fibrinogen by sepharose-plasma chromatography at 20 degrees C and 37 degrees C.

A method for characterising serum fibrinogen and fibrin degradation products.

Fibrin and fibrinogen degradation products in chronic subdural hematoma.

Estimation of fibrinogen-fibrin related antigen by continuous flow analysis.

fibrinogen degradation products in glomerulonephritis.

Urinary fibrin-fibrinogen degradation products in nephrotic syndrome.

Isolation of vasoactive peptides from human fibrin and fibrinogen degraded by plasmin.

Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers.

Autologous whole plasma fibrin gel. Intraoperative procurement.

Lipopolysaccharide-instructed, cryopreserved, human monocytes sequentially convert plasma fibrinogen to fibrin and lyse the fibrin formed.

Recommend Documents

Follow Us